000			02062 a2200553 4500
005			20250515145425.0
264		0	_c20081204
008			200812s 0 0 eng d
022			_a1558-3597
024	7		_a10.1016/j.jacc.2008.07.056 _2doi
040			_aNLM _beng _cNLM
100	1		_aBlair, John E A
245	0	0	_aContinental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cNov 2008
300			_a1640-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBenzazepines _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHeart Failure _xdrug therapy
650	0	4	_aHospitalization
650	0	4	_aHumans
650	0	4	_aInternationality
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Revascularization
650	0	4	_aPacemaker, Artificial _xstatistics & numerical data
650	0	4	_aProspective Studies
650	0	4	_aTolvaptan
650	0	4	_aVasopressins _xantagonists & inhibitors
700	1		_aZannad, Faiez
700	1		_aKonstam, Marvin A
700	1		_aCook, Thomas
700	1		_aTraver, Brian
700	1		_aBurnett, John C
700	1		_aGrinfeld, Liliana
700	1		_aKrasa, Holly
700	1		_aMaggioni, Aldo P
700	1		_aOrlandi, Cesare
700	1		_aSwedberg, Karl
700	1		_aUdelson, James E
700	1		_aZimmer, Christopher
700	1		_aGheorghiade, Mihai
773	0		_tJournal of the American College of Cardiology _gvol. 52 _gno. 20 _gp. 1640-8
856	4	0	_uhttps://doi.org/10.1016/j.jacc.2008.07.056 _zAvailable from publisher's website
999			_c18453398 _d18453398